|Bid||90.93 x 1300|
|Ask||90.97 x 800|
|Day's Range||90.41 - 91.58|
|52 Week Range||70.55 - 94.75|
|Beta (5Y Monthly)||0.96|
|PE Ratio (TTM)||22.54|
|Earnings Date||Jan 29, 2020|
|Forward Dividend & Yield||1.60 (1.76%)|
|Ex-Dividend Date||Nov 13, 2019|
|1y Target Est||93.81|
Moody's Investors Service ("Moody's") affirmed AmerisourceBergen Corporation's ("AmerisourceBergen") Baa2 senior unsecured rating and Prime-2 senior unsecured commercial paper rating. The affirmation of the Baa2 rating reflects Moody's expectation that AmerisourceBergen's cash flow will remain strong, with approximately $1.5 billion of free cash flow after dividends per annum over the next three years.
Two Endo International Inc. subsidiaries have agreed to pay Oklahoma $8.75 million to resolve the state’s investigation into whether the pharmaceutical company had a role in the state’s opioid abuse crisis. The settlement agreement, under which the Endo business units admitted to no wrongdoing or liability, involved Endo Pharmaceuticals Inc. and Par Pharmaceuticals. Endo officials noted the amount it agreed to pay in connection with the settlement agreement is a "fraction" of the settlement and judgment amounts associated with other opioid manufacturers in Oklahoma.
Oklahoma Attorney General Mike Hunter on Monday brought a lawsuit against three distributors of opioids after winning a lawsuit against one drug manufacturer and reaching pretrial settlements in other cases.
Hagens Berman has filed a class-action lawsuit on behalf of investors in Aurora Cannabis Inc. (NYSE: ACB) against the Company.
AmerisourceBergen (ABC) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Zacks.com featured highlights include: Nordstrom, M/I Homes, American Airlines, Covenant Transportation and AmerisourceBergen
AmerisourceBergen Corporation (NYSE: ABC) today announced that it plans to release its results for the First Quarter Fiscal 2020 on Thursday, January 30, 2020, prior to the opening of trading on the New York Stock Exchange. The Company will host a conference call to discuss the results at 8:30 a.m. ET on January 30, 2020.
AmerisourceBergen Corporation (NYSE: ABC) today announced that it will participate in the Goldman Sachs 12th Annual Healthcare CEOs Unscripted Conference on Thursday, January 9, 2020, in New York, NY.
AmerisourceBergen Corporation (NYSE: ABC) today announced that its Board of Directors elected Dennis M. Nally, 67, as a new independent director, effective January 1, 2020. With the election of Mr. Nally, the AmerisourceBergen Board of Directors increased from nine to ten members, eight of whom are independent.
Steve Collis has been the CEO of AmerisourceBergen Corporation (NYSE:ABC) since 2011. This report will, first, examine...
It is already common knowledge that individual investors do not usually have the necessary resources and abilities to properly research an investment opportunity. As a result, most investors pick their illusory “winners” by making a superficial analysis and research that leads to poor performance on aggregate. Since stock returns aren't usually symmetrically distributed and index […]
AmerisourceBergen Corp. is moving forward with an expansion to its pharmaceutical distribution facility near Rickenbacker International Airport even though the city of Columbus has indefinitely delayed an incentive.
AmerisourceBergen (ABC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Low-cost index funds make it easy to achieve average market returns. But if you invest in individual stocks, some are...
We are still in an overall bull market and many stocks that smart money investors were piling into surged through the end of November. Among them, Facebook and Microsoft ranked among the top 3 picks and these stocks gained 54% and 51% respectively. Hedge funds' top 3 stock picks returned 41.7% this year and beat […]
The stock prices of opioid drugmakers and distributors fell this week after news of a possible federal criminal probe, eroding many of the gains made in the weeks since a global settlement resolving opioid litigation was first announced.
Shares of companies caught up in the opioid litigation have risen recently, but a Wall Street Journal report appears to have reminded investors that the trouble could continue.
Shares of some manufacturers and distributors of opioid drugs decline on Tuesday following reports that a criminal probe has been initiated by federal prosecutors.
Pharmaceutical companies are in trouble over their role in fueling the opioid crisis facing the U.S. What Happened Federal authorities have launched a criminal investigation against the companies — using ...
Shares of pharmaceuticals companies Teva, Amneal and Mallinckrodt slumped Tuesday on a report that federal prosecutors have opened a criminal investigation into the opioid epidemic.
Shares of the companies embroiled in opioid litigation fell in afternoon trading afterThe Wall Street Journal reported the federal government had opened a criminal investigation into some opioid makers and distributors, citing sources. Six companies have disclosed in regulatory filings that they have received grand-jury subpoenas from the U.S. attorney's office in the Eastern District of New York, according to the report. Teva Pharmaceutical Industries Ltd. is down 8%, Mallinckrodt 5%, Amneal Pharmaceuticals Inc. 10%, and Johnson & Johnson 1%. Shares of cited wholesale drug distributors also declined, AmerisourceBergen by 3% and McKesson by 5%. In addition, shares of companies facing opioid litigation but not cited in the Journal story also dropped, with Endo International down 9% and Cardinal Health 4%. In recent weeks, the stocks of these companies have rallied as investors took the view that the possibility of global settlement that would resolve all pending and future litigation was a positive.
AmerisourceBergen Corp. plans an expansion to its pharmaceutical distribution facility near Rickenbacker International Airport that would make it the largest in the company.